• UFR-Instituts-Écoles
  • Unités de recherche
    • ENT
    • Contact
    • Plans
    • Bibliothèques
    • Boutique
      • Français (FR)
  • Presentation
  • Research pillars
  • Expertise
  • Team
  • Training in research
  • Publications
  • Contact/Access
Home - LIIC

Immunology and Immunotherapy of Cancer Laboratory

Acquired resistance to conventional chemotherapies and/or tumor escape from immune control often lead to failure of cancer therapy. The LIIC research team focuses on the antitumor properties of nitric oxide (NO), as a sensitizer of cancer cells to death, when used in combination with standard chemotherapeutic agents (Axes of research 1 to 3) or with new immunotherapies (Axes of research 3 and 4).

Research Pillars

  • NO AND CHEMOTHERAPY-INDUCED INFLAMMATION
  • NO AND CHEMORESISTANCE SUPPRESSION
  • NO AND CHEMO/IMMUNOTHERAPIES
  • NO AND KINASE INHIBITORS

Tools & Expertise

Analysis of anti-tumor effects in vitro
Analysis of anti-tumor effects in vivo/ex vivo
Translational research
Identification of biomarkers
Development of novel therapies

 

  • Collaborations
  • Partnerships
  • Contacts
Logo uB

   Equipe d’Accueil : Laboratoire d'Immunologie et Immunothérapie des Cancers - EA 7269
    Université de Bourgogne – Franche Comté
    UFR des Sciences de Santé
    7 Bd Jeanne d’Arc
    21079 Dijon – France

    Tel : (+33) 3 80 39 34 51
    Email : ali.bettaieb@u-bourgogne.fr

  • Legal Terms
  • Cookies Policy
  • Sitemap
  • Français (FR)
  • Presentation
  • Research pillars
  • Expertise
  • Team
  • Training in research
  • Publications
  • Contact/Access